Integro Theranostics
Clinical trials sponsored by Integro Theranostics, explained in plain language.
-
Glow-in-the-Dark dye could help surgeons spot hidden breast cancer
Diagnosis OngoingThis study tests a new dye called LS301-IT that makes cancer cells glow during breast cancer surgery. About 100 women with early-stage breast cancer will receive the dye before their lumpectomy. The goal is to see if the dye helps surgeons remove all cancer while sparing healthy …
Phase: PHASE1, PHASE2 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated May 17, 2026 10:09 UTC
-
Glow-in-the-Dark dye could help surgeons spot lung cancer
Diagnosis OngoingThis early-phase trial tests a new fluorescent dye called LS301-IT that is given to people before lung cancer surgery. The dye aims to make cancer cells glow, helping surgeons see and remove them more precisely. The main goals are to check safety and find the best dose and timing…
Phase: PHASE1 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated May 11, 2026 20:47 UTC